Speaker(s)
During this presentation, we will discuss the prescription medication and heroin epidemic and what the DEA and DEA 360 Strategy are doing to address them.
Objectives:
Speaker(s)
The Emergency Room Enhancement program was initiated by DMH to develop models of effective interventions for people with behavioral health crisis, focusing on individuals who are frequent users of hospital services. The program creates paths to the Community Mental Health Centers and Substance Use Providers for needed care, rather than to the Emergency Departments where they are stabilized and released, often to return again. The DMH recognized the differing needs in each region, allowing the Administrative Agents to build a collaborative that would best meet the needs of their communities. The challenges and strategies specific to building collaboratives in rural vs. urban areas, as well as creative outreach to vulnerable clients, will be presented by providers from the CMHCs.
Speaker(s)
The presentation will be a lively research-based talk, supported by judicious use of PowerPoint slides, and a bit of live music to make things more engaging and enjoyable.
Objectives:
Speaker(s)
Dr. Stanislaus will discuss the prevalence of violence in the Seriously Mentally Ill (SMI) population, and summarize the studies that have examined this issue in various treatment settings and community samples. She will discuss the significance of acute psychotic symptoms such as auditory hallucinations and delusional beliefs in assessing risk of impending violence. She will also discuss early intervention in prevention of violence.
Objectives:
Speaker(s)
Missouri is interested in applying to participate in a federal demonstration project that establishes new federal standards for community behavioral health providers, to be known as “Certified Community Behavioral Health Centers” (CCBHCs) and a Prospective Payment System (PPS) to purchase services from CCBHCs. This presentation describes the goals of the demonstration project, and the new federal standards for CCBHCs in order to provide a context for soliciting input from consumers, family members and other stakeholders in Missouri’s implementation of the CCBHC standards and the demonstration program.
Objectives:
Schuffman STI -What Consumers Families Need to Know About CCBHCs – Slides in PDF format
Speaker(s)
Assaults, self-injury, and hostile relationships are prevalent within inpatient psychiatric hospitals. Unfortunately, these phenomena are known to be unnecessarily maintained by common and well-intentioned treatment practices. The New Outlook Program at SLPRC sought to remove and replace these practices and adopt ones that promoted client self-management in an effort to improve treatment and safety outcomes. The New Outlook Program sought to reduce episodes of assault, self-injury, and use of restraints and to minimize the role of punishing intervention strategies.
Objectives:
Schneider Spring Institute Presentation-Final Slides in PDF format
Speaker(s)
This presentation will provide a summary of research regarding the Glutamate theory of schizophrenia. It will also provide current research regarding the direction of treatment research.
Objectives:
This presentation will provide an introduction to innovative treatment for schizophrenia using cognitive skills and therapy.
Objectives:
Barnhart – Slides in PDF format
Brown Derek glutamatehypo4 – Slides in PDF format
Speaker(s)
This workshop focuses on developing a workplace culture that aims to build Motivational Interviewing (MI) into the DNA of the organization. Too often, time and resources are wasted in training staff in MI in ways that produce very little lasting change in practice. This workshop aims to give a clear definition of MI as a measurable skill, provide strategies that are being successfully utilized by organizations to develop and maintain MI proficiency with their staff, and introduce participants to the wide variety of resources available to aid in the development of a lasting culture of MI.
Objectives:
Speaker(s)
Treatment resistant hallucination leads to poor quality of life and increases in economic burden. TMS has been brain Stimulation technique has shown promising results. The presentation goals are to familiarize the psychiatrists and mental health Professional about history of TMS, Technique and review TMS application studies for Treatment Resistant Hallucination.
The presentation will outline the current utility of the standard EEG in everyday management of psychiatric conditions. The presentation will also briefly cover the areas where future expansion of the role of EEG in managing psychopharmacology are likely to occur in the near future.
Timothy Dellenbaugh, MD
Will discuss genetic influences on psychiatric drug metabolism with specific discussion of Cytochrome P450 2D6. Will review genetic causes and clinical implications of 2D6 phenotypes: ultra-rapid, extensive, intermediate, and poor. Will recommend strategies for learning cytochrome-based drug interactions.
Speaker(s)
This presentation will focus on reviewing and discussing a variety of evidenced-based cognitive behavioral therapies for the treatment of schizophrenia symptoms. Evidence for the efficacy of these interventions will be reviewed, and a brief demonstration of some of the interventions will be provided. Specific consideration will be given to Attention Shaping (Silverstein et. al, 2014), which has been shown to improve attention for individuals with Schizophrenia. A cognitive intervention entitled Michael’s Game (Khazaal et al., 2006) used to treat delusions will also be discussed. A pilot intervention of Michael’s Game to assist clients who are admitted to Fulton State Hospital for competency restoration who are also experiencing significant delusions will be reviewed. Lastly, a discussion concerning the implementation and application of the described interventions in a variety of settings will also be included.
Objectives:
